±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 274  |  »Ø¸´: 1

×¸è

Ìú³æ (³õÈëÎÄ̳)

[ÇóÖú] Ó¢ÎÄ·­Òë³ÉººÓ×ö±¾¿Æ±ÏÒµ·­ÒëÓã¬Òª×¨Òµ£¬Âé·³ÁË

A facile method is employed to prepare a series of LLDPE/PA6 blends with co-continuous morphology
with low PA6 content via reactive extrusion. In these blends, co-continuous morphology is obtained by
introducing graft copolymers with both high and low molecular weight trunk chains to the interface
simultaneously. Maleic anhydride functionalized polybutadine (PB-g-MAH, Mnz3000g=mol and MAH
content¼ 10 wt%) is first melt grafted onto the LLDPE backbones with dicumyl peroxide (DCP) as an
initiator. Part of PB-g-MAH is grafted onto LLDPE to form LLDPE-g-PB-g-MAH copolymer. During reactive
extrusion, in-situ formed Copolymer II (polybutadiene-graft-polyamide, PB-g-PA6) with a low molecular
weight trunk chain (PB) is obtained from the reaction between the maleic anhydride group of free or
non-grafted PB-g-MAH and the amino group on PA6 molecules; while Copolymer I (LLDPE-g-PB-g-PA6)
is obtained via the reaction between the maleic anhydride group of the grafted PB-g-MAH (i.e., LLDPE-g-
PB-g-MAH) and the amino group of PA6. Copolymer I with a high molecular weight trunk chain, LLDPE,
should strengthen the interface and favor stress transfer, enabling the deformation of PA6; and Copolymer
II (PB-g-PA6) with a low molecular weight trunk chain, PB, facilitates the formation of a flat
interface between LLDPE and PA6, thus promoting an elongated PA6 phase. Therefore, co-continuous
morphology of LLDPE/PA6 blend is successfully prepared with only 25 wt% PA6 by controlling suitable
amounts of Copolymers I and II in the blend.

» ²ÂÄãϲ»¶

½»ÅóÓÑ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

×¸è

Ìú³æ (³õÈëÎÄ̳)

ÕæÇ¿±ØÊ¤: ʲôÒâ˼£¿ 2014-09-19 12:38:28
ÔõôÊÕ»Ø
½»ÅóÓÑ
2Â¥2014-09-19 12:31:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ×¸è µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 319·Ö085702°²È«¹¤³ÌÇóµ÷¼Á +3 rious 2026-04-05 3/150 2026-04-06 09:53 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +10 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-05 10/500 2026-04-06 09:35 by jp9609
[¿¼ÑÐ] 301Çóµ÷¼Á +3 XYPLR 2026-04-05 4/200 2026-04-05 19:07 by XYPLR
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +6 cs0106 2026-04-05 6/300 2026-04-05 16:34 by imissbao
[¿¼ÑÐ] µ÷¼Á +11 JLLLLLLLLLL 2026-04-03 11/550 2026-04-04 22:21 by hemengdong
[¿¼ÑÐ] 296²ÄÁÏר˶Çóµ÷¼Á +21 202451007219 2026-04-02 22/1100 2026-04-04 21:48 by hemengdong
[¿¼ÑÐ] Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319 +21 678lucky 2026-03-31 26/1300 2026-04-04 16:22 by dongzh2009
[¿¼ÑÐ] 309Çóµ÷¼Á +6 ÁõÁõÁõ1231 2026-04-02 7/350 2026-04-04 13:41 by liucky
[¿¼ÑÐ] ±¾¿Æ985£¬×¨Òµ0812·Ö336Çóµ÷¼Á +4 ĪĪºÜÐÐ 2026-04-03 4/200 2026-04-03 21:31 by zhq0425
[¿¼ÑÐ] 325·Ö»¯Ñ§µ÷¼Á +5 15771691647 2026-04-02 5/250 2026-04-03 09:58 by ChemPharm
[¿¼ÑÐ] 312Çóµ÷¼Á +6 ССī123 2026-04-02 7/350 2026-04-03 07:32 by jsw79
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-04-02 5/250 2026-04-02 21:16 by ÍÃͻͻͻ£¬
[¿¼ÑÐ] 318Çóµ÷¼Á +3 óÆÐÐÖÂÔ¶. 2026-03-31 4/200 2026-04-02 15:56 by Jaylen.
[¿¼ÑÐ] ³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ +6 axibli 2026-04-01 6/300 2026-04-02 13:42 by Ecowxq666£¡
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +8 cs0106 2026-04-01 9/450 2026-04-02 10:36 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 324Çóµ÷¼Á +5 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 10:16 by sanrepian
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì£¬×Ü·Ö358 +4 cs0106 2026-04-01 4/200 2026-04-02 07:42 by ÉÐË®¸óÖ÷
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-03-31 11/550 2026-04-01 09:43 by xiayizhi
[¿¼ÑÐ] ºÏ·ÊÇøÓòÐÔÖØµãÒ»±¾ÕÐÊÕµ÷¼Á +4 6266jl 2026-03-30 8/400 2026-03-31 18:43 by 6266jl
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û